s pneumoniae d39 rpsl k56t (ATCC)
ATCC is a verified supplier
ATCC manufactures this product
Structured Review
S Pneumoniae D39 Rpsl K56t, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/s pneumoniae d39 rpsl k56t/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Point mutations in functionally diverse genes are associated with increased natural DNA transformation in multidrug resistant Streptococcus pneumoniae"
Article Title: Point mutations in functionally diverse genes are associated with increased natural DNA transformation in multidrug resistant Streptococcus pneumoniae
Journal: Nucleic Acids Research
doi: 10.1093/nar/gkae1140
Figure Legend Snippet: DNA transformation in S. pneumoniae depends on environment and genetic background. ( A ) The transformation efficiency of S. pneumoniae D39 grown as biofilm or planktonic cells was monitored in C + Y and CDM media following exposure to a D39-FolA I100L lysate or D39 WT lysate. The acquisition of the mutation leading to the FolA I100L substitution confers TMP resistance to the transformants. For the C + Y medium, we compared transformation efficiency in the presence (+) and absence (−) of exogenous CSP-1. ( B – E ) The natural transformation efficiency of S. pneumoniae D39, TIGR4, ATCC 49619 and CCRI-14647 grown as biofilms was monitored in media C + Y, BHI, CDM or Columbia following exposure to a D39-RpsL K56T lysate. Transformation efficiency is reported as the number of antibiotic-resistant transformants over the number of viable cells. Each point represents a biological replicate. Transformation efficiencies were compared using the Kruskal–Wallis test followed by Dunn’s test. Significance is indicated as follows: * P < 0.05; ** P < 0.01; *** P < 0.001.
Techniques Used: Transformation Assay, Mutagenesis
Figure Legend Snippet: Selection for increased transformation efficacy in S. pneumoniae D39 using Mut-Seq. ( A ) Overview of the Mut-Seq screen. S. pneumoniae D39 mutagenized with EMS and grown as biofilm in C + Y medium in 24-well plates were exposed to a cell lysate derived from S. pneumoniae D39 coding for the FolA I100L variant, which confers resistance to TMP. Transformants were selected on TMP-containing agar plates and grown again as biofilms in C + Y medium in 24-well plates. No TMP-resistant transformants were obtained from nonmutagenized control cells processed in parallel. To ascertain that the TMP-resistant phenotype results from increased transformation efficiency and not directly from mutagenesis, 110 randomly picked TMP-resistant transformants were subjected to a second round of transformation using a cell lysate derived from S. pneumoniae D39 coding for the RpsL K56T variant, which confers resistance to STR. This led to 39 transformants resistant to both TMP and STR, whose genomes were sequenced. Of these, 19 had acquired the expected FolA I100L at the first round of transformation and were as such considered to have genuine increased natural transformation capacities. ( B ) The increased natural transformation efficiency of the 19 S. pneumoniae D39 FolA I100L -positive transformants derived from the Mut-Seq screen was further assessed as biofilm in C + Y following exposure to a D39-RpsL K56T lysate. Transformation efficiency is reported as the number of STR-resistant transformants over the number of viable cells. Error bars represent the standard error calculated from biological replicates ( n = 6). Transformation efficiencies were compared with the one of D39 wild type (WT) using the Kruskal–Wallis test followed by Dunn’s test. ** P < 0.01. ( C ) A selection of six mutations detected by Mut-Seq in at least two independent mutants (see Table ) along with two mutations not expected to increase natural transformation were introduced in the genome of S. pneumoniae D39. The natural transformation efficiency of the transformants was monitored with cells grown as biofilms in C + Y following exposure to a cell lysate derived from S. pneumoniae D39 coding for the FolA I100L variant. Transformation efficiency is reported as the number of TMP-resistant cells over the number of viable cells. Each point represents a biological replicate. Transformation efficiencies were compared with the one of D39 using the Kruskal–Wallis test followed by Dunn’s test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Techniques Used: Selection, Transformation Assay, Derivative Assay, Variant Assay, Control, Mutagenesis
Figure Legend Snippet: Mut-Seq derived mutations in genes detected in at least two S. pneumoniae D39 transformants
Techniques Used: Derivative Assay
Figure Legend Snippet: Mutations in diverse genes intersecting with Mut-Seq and GWAS screens increase natural transformation in S. pneumoniae . Mutations detected in PurD ( A ), PurH ( B ), Cps2O ( C ) and ScrR ( D ) by Mut-Seq (blue) or in the two GWAS screens (tan, GWAS-1; beige, GWAS-2) were introduced in S. pneumoniae D39. The natural transformation efficiency of the transformants was monitored with planktonic cells grown in C + Y media following exposure to a cell lysate derived from S. pneumoniae D39 coding for the FolA I100L variant. Transformation efficiency is reported as the number of TMP-resistant cells over the number of viable cells. Each point represents a biological replicate. Transformation efficiencies were compared with those of D39 using the Kruskal–Wallis test followed by Dunn’s test. Significance is indicated above the whiskers as follows: * P < 0.05; ** P < 0.01; *** P < 0.001. For the GWAS screens, mutations positively associated with MDR are aligned under the “+” sign whereas those either not associated with MDR (GWAS-1) or positively associated with antibiotic susceptibility (GWAS-2) are aligned under the “−” sign. The significance levels of the association with MDR (GWAS-1, + and −; GWAS-2, +) or susceptibility (GWAS-2, −) prior to and after correction for population structure are indicated within parentheses (uncorrected/corrected) below the mutations on the x -axis as follows: * P = 10 −06 –10 −10 ; ** P = 10 −10 –10 −20 ; *** P = 10 −20 –10 −40 . See Table for the complete GWAS-1 and GWAS-2 data. NA on the x -axis indicates that no mutation was found for the screen in the gene.
Techniques Used: Transformation Assay, Derivative Assay, Variant Assay, Mutagenesis